Suppr超能文献

SARS-CoV-2 关键突变在维也纳的大规模筛查计划中被检测到的进化。

Evolution of SARS-CoV-2 Key Mutations in Vienna Detected by Large Scale Screening Program.

机构信息

Division of Infectious Diseases, Department of Medicine 1, Medical University of Vienna, 1090 Vienna, Austria.

Lifebrain Covid Laboratory GmbH, 1140 Vienna, Austria.

出版信息

Viruses. 2021 Oct 7;13(10):2014. doi: 10.3390/v13102014.

Abstract

Currently countries across the globe are preparing for the fourth wave of SARS-CoV-2 infections, which is mainly driven by the rapid spread of novel SARS-CoV-2 variants. Austria and, in particular, the capital city of Vienna, witnessed a disproportionally steep rise in SARS-CoV-2 infection rates during the last wave of infections. By the end of January 2021, the government of Vienna launched an innovative, state-wide SARS-CoV-2 screening program based on PCR analysis of self-collected mouthwash samples. More than 400,000 mouthwash samples were collected in Vienna during the third wave of infection from January to March 2021. All preanalytical and analytical steps were carried out in a highly standardized manner at a single certified testing center. SARS-CoV-2 specific PCR analysis revealed in these samples a positivity rate of 0.43%. The relative proportion of N501Y positive virus samples increased continually to 68% of weekly samples. Mutation K417N was detected only in three samples. With this study, we were able to map the temporal occurrence of SARS-CoV-2 variants in a highly unbiased manner. Positivity rates and variant prevalence rates in this study were lower than in other nationwide programs. The results presented in this study indicate that actual virus prevalence tends to be overestimated by surveillance programs such as results of cluster analysis or contact tracing programs.

摘要

目前,全球各国都在为第四波 SARS-CoV-2 感染做准备,这主要是由新型 SARS-CoV-2 变体的快速传播驱动的。奥地利,特别是维也纳,在上一波感染中经历了 SARS-CoV-2 感染率的不成比例的急剧上升。到 2021 年 1 月底,维也纳政府启动了一项基于自我采集的漱口样本聚合酶链反应(PCR)分析的创新的、全州范围的 SARS-CoV-2 筛查计划。在 2021 年 1 月至 3 月的第三次感染浪潮中,维也纳共采集了超过 40 万个漱口样本。所有的预分析和分析步骤都在一个经过认证的检测中心以高度标准化的方式进行。在这些样本中,SARS-CoV-2 特异性 PCR 分析显示阳性率为 0.43%。每周样本中 N501Y 阳性病毒样本的相对比例不断增加,达到 68%。仅在三个样本中检测到 K417N 突变。通过这项研究,我们能够以高度无偏倚的方式绘制 SARS-CoV-2 变体的时间发生情况。本研究中的阳性率和变异体流行率低于其他全国性计划。本研究的结果表明,监测计划(如聚类分析或接触者追踪计划的结果)往往会高估实际病毒流行率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6818/8538562/b68b7051ff52/viruses-13-02014-g001.jpg

相似文献

5
CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.基于 CRISPR-Cas12a 的主要关注 SARS-CoV-2 变体检测。
Microbiol Spectr. 2021 Dec 22;9(3):e0101721. doi: 10.1128/Spectrum.01017-21. Epub 2021 Nov 17.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验